NCT04311424View on ClinicalTrials.gov

Study of Tirzepatide in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

October 2, 2020

Study Completion Date

October 2, 2020

Conditions
Healthy
Interventions
DRUG

14C Tirzepatide

Administered SC.

Trial Locations (1)

LS2 9LH

Covance Clinical Research Ltd, Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04311424 - Study of Tirzepatide in Healthy Participants | Biotech Hunter | Biotech Hunter